Selection and characterization of heat-resistant variants of multidrug-resistant human gastric carcinoma cell lines

被引:0
|
作者
Jordan, A [1 ]
Scholz, R [1 ]
机构
[1] Univ Med Berlin, Charite, Dept Radiol, CBN, Berlin, Germany
关键词
thermoresistance; multidrug resistance; thermosensitivity; thermotolerance; hyperthermia;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To generate heat resistant variants selected from established human gastric carcinoma cell lines exhibiting different types of multidrug resistance (MDR) phenotype, i.e. EPG85-257P, the drug sensitive parental cell-line, EPG85-257RDB, a classical MDR subline and EPG85-257RNOV, which is an atypical multidrug resistant subline. Methods: Thermoresistance was induced by stepwise increase of the growth temperature from 37.0 to 39.4 degrees C. Thermoresistance was determined by change of population doubling time (PDT) and clonogenic survival after acute hyperthermia at 42, 43, 44 and 45 degrees C. Results: Most of the cells exhibited necrosis at elevated culture temperature. The PDT of the surviving thermoresistant variants were increased two-fold (EPG85-257P-TR) and 1.2-fold (EPG85-257RNOV-TR), respectively. No PDT change was observed with the lowest thermoresistant subline EPG85-257RDB-TR. Dose response curves after acute hyperthermia indicated a stable increase of thermotolerance of the parental cell line and the atypical MDR subline (50-90-fold at 45 degrees C), but not of the classical MDR subline, which was only increased at 43 degrees C (3-4-fold). Acquired thermoresistance did not change after freezing/thawing procedures. Conclusion: All cell lines achieved chronically induced thermoresistance. Thermotolerance after acute hyperthermia. was present in the drug sensitive parental cell line and the atypical MDR subline, but not in cells exhibiting a classical MDR phenotype.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [1] Establishment and Characterization of Multidrug-resistant Gastric Cancer Cell Lines
    Zhang, Xiaotian
    Yashiro, Masakazu
    Qiu, Hong
    Nishii, Takafumi
    Matsuzaki, Taro
    Hirakawa, Kosei
    ANTICANCER RESEARCH, 2010, 30 (03) : 915 - 921
  • [2] ESTABLISHMENT AND CHARACTERIZATION OF MULTIDRUG-RESISTANT HUMAN OSTEOSARCOMA CELL-LINES
    SERRA, M
    SCOTLANDI, K
    MANARA, MC
    MAURICI, D
    LOLLINI, PL
    DEGIOVANNI, C
    TOFFOLI, G
    BALDINI, N
    ANTICANCER RESEARCH, 1993, 13 (02) : 323 - 329
  • [3] Thermosensitivity of multidrug-resistant human gastric and pancreatic carcinoma cells
    Lage, H
    Jordan, A
    Scholz, R
    Dietel, M
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2000, 16 (04) : 291 - 303
  • [4] SELECTION AND CHARACTERIZATION OF VERAPAMIL-RESISTANT MULTIDRUG-RESISTANT CELLS
    CANOGAUCI, DF
    SEIBERT, FS
    SAFA, AR
    RIORDAN, JR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (02) : 497 - 505
  • [5] Establishment of new multidrug-resistant human osteosarcoma cell lines
    Oda, Y
    Matsumoto, Y
    Harimaya, K
    Iwamoto, Y
    Tsuneyoshi, M
    ONCOLOGY REPORTS, 2000, 7 (04) : 859 - 866
  • [6] GENES AMPLIFIED AND OVEREXPRESSED IN HUMAN MULTIDRUG-RESISTANT CELL-LINES
    VANDERBLIEK, AM
    BAAS, F
    VANDERVELDEKOERTS, T
    BIEDLER, JL
    MEYERS, MB
    OZOLS, RF
    HAMILTON, TC
    JOENJE, H
    BORST, P
    CANCER RESEARCH, 1988, 48 (21) : 5927 - 5932
  • [7] The effect of arsenic trioxide on multidrug-resistant human leukemia cell lines
    Seo, T
    Urasaki, Y
    Takemura, H
    Ueda, T
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 145 - 145
  • [8] THE EFFLUX OF ANTHRACYCLINES IN MULTIDRUG-RESISTANT CELL-LINES
    COLEY, HM
    TWENTYMAN, PR
    WORKMAN, P
    BIOCHEMICAL PHARMACOLOGY, 1993, 46 (08) : 1317 - 1326
  • [9] Mechanism of Quercetin as a Multidrug-resistant Reversing Compound in Oxaliplatin-resistant Gastric-cancer Cell Lines
    Zhao, Guodong
    Xue, Siwei
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2023, 29 (08) : 54 - 59
  • [10] P-GLYCOPROTEIN EXPRESSION IN MULTIDRUG-RESISTANT HUMAN OVARIAN-CARCINOMA CELL-LINES
    BRADLEY, G
    NAIK, M
    LING, V
    CANCER RESEARCH, 1989, 49 (10) : 2790 - 2796